Locally advanced prostatic cancer: Long-term toxicity outcome after three-dimensional conformal radiation therapy - A dose-escalation study

Radiology

Volumn 209, Issue 1, 1998, Pages 169-174

  Zelefsky, Michael J ^a   Fuks, Zvi ^a   Wolfe, Theresa ^a   Kutcher, Gerald J ^a   Burman, Chandra ^a   Ling, C Clifton ^a   Venkatraman, E S ^a   Leibel, Steven A ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Prostate, neoplasms; Prostate, therapeutic radiology; Radiations, injurious effects, complications of therapeutic radiology; Treatment planning

Indexed keywords

ACID PHOSPHATASE; ALKALINE PHOSPHATASE; FLUTAMIDE; LEUPRORELIN; PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FOLLOW UP; HUMAN; MALE; MICTURITION DISORDER; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; RADIATION INJURY; RECTUM HEMORRHAGE; URETHRA STRICTURE;

EID: 0031719028     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.209.1.9769828     Document Type: Article

References (26)

1. Hanks GE, Martz KL, Diamond JJ. The effect of dose on local control of prostate cancer. Int J Radiat Oncol Biol Phys 1988; 15:1299-1305.
2. Smit WGJM, Helle PA, van Putten WLJ, Wijnmalalen AJ, Seldenrath JJ, ven Der Werf-Messing BHP. Late radiation damage in prostate cancer patients treated by high dose external radiotherapy in relation to rectal dose. Int J Radiat Oncol Biol Phys 1990; 18:23-29.
3. Leibel SA, Zelefsky MJ, Kutcher GJ, Burman CM, Kelson S, Fuks Z. Three-dimensional conformai radiation therapy in localized carcinoma of the prostate: interim report of a phase 1 dose-escalation study. J Urol 1994; 152:1792-1798.
4. Zelefsky MJ, Leibel SA, Kutcher GJ, Kelson S, Ling CC, Fuks Z. The feasibility of dose escalation with three-dimensional conformal radiotherapy in patients with prostatic carcinoma. Cancer J Sci Am 1995; 1:42-50.
5. Shipley WU, Verhey LJ, Munzenrider JE, et al. Advanced prostate cancer: the results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone. Int J Radiat Oncol Biol Phys 1995; 32:3-12.
6. Hanks GE, Lee WR, Hanlon AL, et al. Conformal technique dose escalation for prostate cancer: biochemical evidence of improved cancer control with higher doses in patients with pretreatment prostate-specific antigen >10 ng/mL. Int J Radiat Oncol Biol Phys 1996; 35:862-868.
7. Roach M III, Meehan S, Kroll S, et al. Radiotherapy for high grade clinically localized adenocarcinoma of the prostate. J Urol 1996; 156:1719-1723.
8. Pollack A, Zagars GK. External beam radiotherapy dose-response of prostate cancer. Int J Radiat Oncol Biol Phys 39:1011-1018.
9. Fukanja-Johnson N, Sandler HM, McLaughlin PW, et al. Results of 3D conformal radiotherapy in the treatment of localized prostate cancer. Int J Radiat Oncol Biol Phys 1997; 38:311-317.
10. Forman JD, Duclos M, Shamsa F, Porter AT, Orton C. Hyperfractionated conformal radiotherapy in locally advanced prostate cancer: results of a dose escalation study. Int J Radiat Oncol Biol Phys 1996; 34:655-662.
11. Zelefsky MJ, Leibel SA, Gaudin PB, et al. Dose escalation with three-dimensional conformal radiotherapy affects the outcome in prostate cancer. Int J Radiat Oncol Biol Phys 1998; 41:491-500.
12. Lawton CA, Won M, Pilepich MV, et al. Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: analysis of RTOG studies 7506 and 7706. Int J Radiat Oncol Biol Phys 1991; 21:935-939.
13. American Joint Committee on Cancer. Prostate. In: Beahrs OH, Henson DE, Hutter RVP, Kennedy BJ, eds. Manual for staging of cancer. 4th ed. Philadelphia, Pa: Lippincott, 1992; 181-183.
14. Gleason DF. Histologic grading and clinical staging of prostatic carcinoma. In: Tannenbaum M, ed. Urologic pathology: the prostate. Philadelphia, Pa: Lea & Febiger, 1977; 171-197.
15. Zelefsky MJ, Leibel SA, Burman CM, et al. Neoadjuvant hormonal therapy improves the therapeutic ratio in patients with bulky prostatic cancer treated with three-dimensional conformal radiation therapy. Int J Radiat Oncol Biol Phys 1994; 29:755-761.
16. Zelefsky MJ, Harrison A. Neoadjuvant androgen ablation prior to radiotherapy for prostate cancer: reducing the potential morbidity of therapy. Urology 1997; 49: 38-45.
17. Leibel SA, Zelefsky MJ, Kutcher GJ, et al. The biological basis and clinical application of three-dimensional conformal external beam radiation therapy in carcinoma of the prostate. Semin Oncol 1994; 21:580-597.
18. Zelefsky MJ, Happersett L, Leibel SA, et al. The effect of treatment positioning on normal tissue dose in patients with prostate cancer treated with three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 1997; 37:13-19.
19. Kaplan EL, Meier P. Nonparametic estimation from incomplete observations. J Am Stat Assoc 1958; 53:457-816.
20. Mantel N. Evaluation of survival data and two rank order statistics arising in its consideration. Cancer Chemother Rep 1966; 50:163-170.
21. Leibel SA, Hanks GE, Kramer S. Patterns of care outcome studies: results of the national practice in adenocarcinoma of the prostate. Int J Radiat Oncol Biol Phys 1984; 10:401-409.
22. Sandler HM, McLaughlin PW, Ten Haken RK, Addison H, Forman J, Lichter A. Three dimensional conformal radiotherapy for the treatment of prostate cancer: low risk of chronic rectal morbidity observed in a large series of patients. Int J Radiat Oncol Biol Phys 1996; 34:655-662.
23. Schultheiss TE, Lee WR, Hunt MA, Hanlon AL, Peter RS, Hanks GE. Late GI and GU complications in the treatment of prostate cancer. Int J Radiat Oncol Biol Phys 1997; 37:3-11.
24. Lee WR, Hanks GE, Hanlon A, Schultheiss TE, Hunt MA. Lateral rectal shielding reduces late rectal morbidity following high dose three-dimensional conformal radiotherapy for clinically localized prostate cancer: further evidence of a significant dose effect. Int J Radiat Oncol Biol Phys 1996; 35:251-257.
25. Ling CC, Burman C, Chui CS, et al. Conformal radiation treatment of prostate cancer using inversely-planned intensity-modulated photon beams produced with multileaf collimation. Int J Radiat Oncol Biol Phys 1996; 35:721-730.
26. Mohan R, Zelefsky M, Yang J, et al. The potential of optimized intensity modulation to escalate prostate dose to 86.4 Gy. Int J Radiat Oncol Biol Phys 1996; 36:197.